NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics

Journal of Human Hypertension

Volumn 20, Issue 10, 2006, Pages 772-779

  Castejon, A M ^a   Bracero, J ^a   Hoffmann, I S ^b   Alfieri, A B ^b   Cubeddu, L X ^a,b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CYSTEINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CHLORIDE; THREONINE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISPANIC; HUMAN; HYPERINSULINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

ADULT; ALLELES; BIOLOGICAL MARKERS; BLOOD PRESSURE; CONTINENTAL POPULATION GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; HYPERINSULINISM; HYPERTENSION; MALE; MIDDLE AGED; NADPH OXIDASE; NITRIC OXIDE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VENEZUELA;

EID: 33748940436     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002057     Document Type: Article

References (41)

1. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y et al. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 1999; 100: 1494-1498.
2. Wang HD, Pagano PJ, Du Y, Cayatte AJ, Quinn MT, Brecher P et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 1998; 82: 810-818.
3. Ronson RS, Nakamura M, Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 1999; 44: 47-59.
4. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
5. Meng S, Roberts II LJ, Cason GW, Curry TS, Manning Jr RD. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 2002; 283: 732-738.
6. Trolliet MR, Rudd MA, Loscalzo J. Oxidative stress and renal dysfunction in salt-sensitive hypertension. Kidney Blood Press Res 2001; 24: 116-123.
7. Fenoy FJ, Ferrer P, Carbonell L, Garcia-Salom M. Role of nitric oxide on papillary blood flow and pressure-natriuresis. Hypertension 1995: 25: 408-414.
8. Ikenaka H, Suzuki H, Ishii N, Itoh H, Saruta T. Role of NO on pressure natriuresis in Wistar-Kyoto rats and spontaneously hypertensive rats. Kidney Int 1993; 43: 205-211.
9. Hu L, Manning Jr RD. Role of nitric oxide in regulation of long-term pressure - natriuresis relationship in Dahl rats. Am J Physiol 1995; 268: H2375-H2383.
10. Chen PY, Gladish RD, Sanders PW. Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-sensitive rats. Hypertension 1998; 31: 918-924.
11. Castejon AM, Alfieri AB, Hoffmann IS, Rathinavelu A, Cubeddu LX. Alpha-adducin polymorphism, salt sensitivity, nitric oxide excretion, and cardiovascular risk factors in normotensive Hispanics. Am J Hypertens 2003; 16: 1018-1024.
12. Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Alfieri AB, Cubeddu LX. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005; 19: 233-240.
13. Cubeddu LX, Alfieri AB, Hoffmann IS, Jimenez E, Roa CM, Cubeddu R et al. Nitric oxide and salt sensitivity. Am J Hypertens 2000; 13: 973-979.
14. Rae J, Noack D, Heyworth PG, Ellis BA, Curnutte JT, Gross AR. Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox). Blood 2000, 96: 1106-1112.
15. Schächinger V, Britten MB, Dimmeler S, Zeiher AM. NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur Heart J 2001; 22: 96-101.
16. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998; 97: 135-137.
17. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N et al. C242T polymorphism. of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000; 31: 936-939.
18. Ji Z, Lu BX, Wang XY, Pan SY. C242T p22phox gene polymorphism in the population of Han nationality in Guangdong province. Di Yi Jun Yi Da Xue Xue Boo 2003; 23: 387-390.
19. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin Chim Acta 2004; 350: 51-55.
20. Mata-Balaguer T, de la Herran R, Ruiz-Rejon C, Ruiz-Rejon M, Garrido-Ramos MA, Ruiz-Rejon F. Angiotensin-converting enzyme and p22(phos) polymorphisms and the risk of coronary heart disease in a low-risk spanish population, Int J Cardiol 2004; 95: 145-151.
21. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004; 25: 970-977.
22. Cai H, Duarte N, Wilcken DE, Wang XL. NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest 1999; 29: 744-748.
23. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002; 39: 269-274.
24. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000; 102: 1744-1747.
25. Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N et al. Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 2003; 26: 458-463.
26. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 1999; 145: 315-323.
27. Li A, Prasad A, Mincemoyer R, Satorius C, Epstein N, Finkel T et al. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 1999; 86: 57-61.
28. Weinberger MH. Sodium and volume sensitivity of blood pressure: Age and pressure change over time. Hypertension 1991; 8: 67-71.
29. Bigazzi R, Bianchi S, Baldari G, Campese VM. Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: Role of insulin. Am J Hypertens 1996; 9: 24-32.
30. Campese VM. Salt sensitivity in hypertension: Renal and cardiovascular implications. Hypertension 1994; 23: 531-550.
31. Fuenmayor NT, Moreira E Cubeddu LX. Salt sensitivity and insulin resistance in essential hypertension. Am J Hypertens 1998; 4: 397-402.
32. Sharma AM. Salt sensitivity as a phenotype for genetic studies of human hypertension. Nephrol Dial Trasplant 1996; 11: 927-929.
33. Luft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Daugherty SA et al. Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension 1991; 17: 1102-1108.
34. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997; 350: 1734-1737.
35. Coca A, De la Sierra A. Salt sensitivity and left ventricular hypertrophy. Adv Exp Med Biol 1997; 432: 91-101.
36. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001; 37: 429-432.
37. Bihorac A, Tezcan H, Ozener C, Oktay A, Akoglu E. Association between salt sensitivity and target organ damage in essential hypertension. Am J Hypertens 2000; 3: 864-872.
38. Weinberger MH. Salt sensitivity is associated with an increased mortality in both normal and hypertensive humans. J Clin Hypertens (Greenwich) 2002; 4: 274-276.
39. Pechere-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004; 17: 994-1001.
40. Tolins JP, Shultz PJ. Endogenous nitric oxide determines sensitivity to the pressor effect of salt. Kidney Int 1994; 46: 230-236.
41. Schulman IH, Zhou MS, Raij L. Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis. Curr Hypertens Rep 2005; 7: 61-67.